Oculis Holding (OCS) Price & Analysis

Compare

71 Followers

OCS Stock Chart & Stats

Day’s Range― - ―

52-Week Range$10.79 - $23.08

Previous CloseN/A

Volume95.89K

Average Volume (3M)13.38K

Market Cap

$972.88M

Enterprise Value$714.07M

Total Cash (Recent Filing)$98.66M

Total Debt (Recent Filing)$1.18M

Price to Earnings (P/E)―

Beta0.38

Next Earnings

Aug 19, 2025

EPS Estimate

-0.56

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.86

Shares Outstanding54,533,672

10 Day Avg. Volume14,264

30 Day Avg. Volume13,379

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market Cap0.73

Enterprise Value/Revenue1.53K

Enterprise Value/Gross Profit-26.59

Enterprise Value/Ebitda-8.30

Forecast

1Y Price Target

$36.25

Price Target Upside102.06% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering4

Bulls Say, Bears Say

Bulls Say

Market PotentialPrivosegtor demonstrated a neuroprotection effect by reducing retinal thinning and improving visual benefits in patients with acute optic neuritis.

Regulatory ProgressManagement has made a strategic decision to submit the New Drug Application for OCS-01 for the treatment of inflammation and pain following ocular surgery after the NDA submission for diabetic macular edema.

Strategic ExpansionThe company has strengthened its position with three strong assets, expanding from the initial two assets.

Bears Say

Clinical Trial RisksRisks include possible failure of OCS-01 or OCS-02 in clinical trials or to secure regulatory approval, as well as potential dilution risk.

Regulatory ChallengesPossible failure to secure regulatory approval for OCS-01 or OCS-02 may impact the company's growth prospects.

Oculis Holding News

Oculis Holding AG Secures Amended Loan Agreement with Kreos Capital

Oculis Holding ( ($OCS) ) has issued an update. Oculis Holding AG, a company based in Zug, Switzerland,...

7d ago

OCS

Oculis Holding AG Announces 2025 AGM Results and Strategic Approvals

Oculis Holding ( ($OCS) ) has shared an update. On June 5, 2025, Oculis Holding AG announced the...

2M ago

OCS

Oculis Holding’s Promising Pipeline and Strategic Initiatives Drive Buy Rating

Oculis Holding (OCS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today....

3M ago

OCS

Oculis Announces 2025 Annual General Meeting Details

Oculis Holding ( ($OCS) ) has shared an update. On May 9, 2025, Oculis Holding AG announced the...

3M ago

OCS

Oculis Holding AG Reports Strong Q1 Progress

Oculis Holding Ag ( ($OCS) ) has released its Q1 earnings. Here is a breakdown of the information...

3M ago

OCS

Oculis Holding AG Reports Q1 2025 Financial Results

An announcement from Oculis Holding ( ($OCS) ) is now available. On May 8, 2025, Oculis Holding AG...

3M ago

OCS

Oculis price target raised to $32 from $29 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Oculis (OCS) to $32 from $29 and keeps a Buy...

4M ago

OCS

Oculis Holding’s Promising Future: Advancements in Neuroprotection, Dry Eye Treatment, and Diabetic Macular Edema

Leerink Partners analyst Marc Goodman has maintained their bullish stance on OCS stock, giving a Buy rating on...

4M ago

OCS

Oculis Holding AG Unveils Key Clinical Updates and Future Outlook at R&D Day

Oculis Holding ( ($OCS) ) has issued an announcement. On April 15, 2025, Oculis Holding AG held an...

4M ago

OCS

Oculis Holding’s Promising Pipeline and Strategic FDA Alignments Support Buy Rating

Leerink Partners analyst Marc Goodman maintained a Buy rating on Oculis Holding (OCS – Research Report) on March...

5M ago

OCS

Oculis price target raised to $41 from $37 at Baird

Baird analyst Colleen Kusy raised the firm’s price target on Oculis (OCS) to $41 from $37 and keeps...

5M ago

OCS

Oculis price target raised to $32 from $31 at BofA

BofA analyst Jason Gerberry raised the firm’s price target on Oculis (OCS) to $32 from $31 and keeps...

5M ago

OCS

Oculis price target lowered to $29 from $30 at H.C. Wainwright

H.C. Wainwright lowered the firm’s price target on Oculis (OCS) to $29 from $30 and keeps a Buy...

5M ago

OCS

Oculis Holding AG Faces Heightened Cybersecurity Risks Amid Geopolitical Tensions

Oculis Holding Ag (OCS) has disclosed a new risk, in the Cyber Security category. Oculis Holding AG faces...

5M ago

OCS

OCS FAQ

What was Oculis Holding Ag’s price range in the past 12 months?

Oculis Holding Ag lowest stock price was $10.79 and its highest was $23.08 in the past 12 months.

What is Oculis Holding Ag’s market cap?

Oculis Holding Ag’s market cap is $972.88M.

When is Oculis Holding Ag’s upcoming earnings report date?

Oculis Holding Ag’s upcoming earnings report date is Aug 19, 2025 which is in 11 days.

How were Oculis Holding Ag’s earnings last quarter?

Oculis Holding Ag released its earnings results on May 08, 2025. The company reported -$0.864 earnings per share for the quarter, missing the consensus estimate of -$0.537 by -$0.327.

Is Oculis Holding Ag overvalued?

According to Wall Street analysts Oculis Holding Ag’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Oculis Holding Ag pay dividends?

Oculis Holding Ag does not currently pay dividends.

What is Oculis Holding Ag’s EPS estimate?

Oculis Holding Ag’s EPS estimate is -0.56.

How many shares outstanding does Oculis Holding Ag have?

Oculis Holding Ag has 54,533,672 shares outstanding.

What happened to Oculis Holding Ag’s price movement after its last earnings report?

Oculis Holding Ag reported an EPS of -$0.864 in its last earnings report, missing expectations of -$0.537. Following the earnings report the stock price went down -0.642%.

Which hedge fund is a major shareholder of Oculis Holding Ag?

Currently, no hedge funds are holding shares in OCS

Oculis Holding Stock Smart Score

Underperform

Fundamentals

Return on Equity

-85.39%

Trailing 12-Months

Asset Growth

110.56%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Oculis Holding Ag

Oculis Holding (OCS) is a biopharmaceutical company focused on the development and commercialization of innovative ophthalmic treatments. The company operates in the healthcare sector, specifically targeting eye diseases and conditions. Oculis aims to address unmet medical needs through its portfolio of advanced therapeutic candidates designed to improve patient outcomes in various ophthalmic indications.

Oculis Holding (OCS) Earnings & Revenues

Historic Earnings Reports

OCS Stock 12 Month Forecast

Average Price Target

$36.25

▲(102.06% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"10":"$10","51":"$51","20.25":"$20.3","30.5":"$30.5","40.75":"$40.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":50,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$50.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":36.25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$36.25</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":28,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$28.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[10,20.25,30.5,40.75,51],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2024","6":"Oct<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.22,21.587692307692308,23.955384615384617,26.323076923076922,28.69076923076923,31.05846153846154,33.426153846153845,35.793846153846154,38.16153846153846,40.52923076923077,42.89692307692308,45.26461538461538,47.63230769230769,{"y":50,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.22,20.529999999999998,21.84,23.15,24.46,25.77,27.08,28.39,29.7,31.009999999999998,32.32,33.629999999999995,34.94,{"y":36.25,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.22,19.895384615384614,20.57076923076923,21.246153846153845,21.92153846153846,22.596923076923076,23.27230769230769,23.947692307692307,24.623076923076923,25.298461538461538,25.973846153846154,26.64923076923077,27.324615384615385,{"y":28,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":12,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.62,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.85,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.76,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.45,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.09,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.88,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.58,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.66,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.73,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.22,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >